Microarray Analysis for Activity-Dependent Gene Pairs
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively identify and target activity-dependent gene pairs, particularly long non-coding RNAs (lncRNAs) and protein-coding mRNAs, which are differentially expressed in brain tissue with varying electrical activity, posing challenges for therapeutic intervention in conditions like epilepsy.
Innovation Solution
A method involving microarray analysis to identify putative therapeutic targets by quantifying lncRNA and mRNA expression in brain tissue samples with different electrical activity levels, linking differentially expressed lncRNA/mRNA pairs, and targeting these pairs for therapeutic intervention using gene silencing or activation techniques.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If microarray analysis is used to quantify lncRNA and mRNA expression, then identification accuracy of activity-dependent gene pairs is improved, but device complexity and cost increase
Solution Approach 1:
The microarray platform is designed to simultaneously detect both lncRNA and mRNA expression levels in a single experiment, allowing the same device to perform multiple functions (quantifying different RNA types) rather than requiring separate assays for each RNA class
Solution Approach 2:
The analysis is divided into distinct segments: lncRNA quantification, mRNA quantification, differential expression analysis, and gene pair linking. This segmentation allows complex analysis to be broken into manageable steps that can be processed systematically
2Measurement precision
If transcriptome-wide analysis of lncRNAs is performed, then therapeutic target identification is improved, but loss of time and computational resources increases
Solution Approach 1:
Differentially expressed genes are identified first by comparing high-activity vs low-activity brain samples before linking them into gene pairs. This preliminary identification step filters the data to focus only on relevant genes, reducing subsequent analysis time
Solution Approach 2:
The analysis uses feedback loops where differential expression results inform the gene pair linking process, and validated gene pairs provide feedback on which regulatory relationships are most significant for therapeutic targeting
3Reliability
If gene silencing or activation techniques are used to target identified gene pairs, then therapeutic effectiveness is improved, but device complexity and treatment complexity increases
Solution Approach 1:
The identified lncRNA-mRNA or lncRNA-lncRNA gene pairs serve as intermediaries that mediate the therapeutic effect. By targeting these specific RNA molecules through silencing or activation, the treatment achieves effectiveness while the intermediary nature of these pairs simplifies the therapeutic mechanism compared to targeting complex protein networks
Data Source
AI summary
Activity-dependent gene pairs as therapeutic targets and methods and devices to identify the same are provided. The methods and devices allow transcriptome-wide analysis of regulatory long non-coding RNAs (lncRNAs), matched with differentially expressed protein-coding genes (mRNAs) and/or with other lncRNAs. The described methods and devices allow analysis of these activity-dependent gene pairs as therapeutic targets in a number of clinical conditions associated with altered electrical brain activity, including epilepsy.